Stanford-led studies show that physicians supported by AI chatbots match or exceed chatbot-alone performance in nuanced clinical decision-making.
Key Details
- 1Stanford Medicine and partners studied chatbots (LLMs) for clinical management reasoning, including imaging-based decisions.
- 2Chatbots alone outperformed doctors using only online references in nuanced management cases, but doctors with chatbot support performed equally well as chatbots alone.
- 3One randomized trial with 70 doctors found best results when AI and physicians independently reviewed cases, followed by AI-generated summary reconciliation.
- 4Studies involved scenarios such as selecting next steps for lung masses detected in imaging.
- 5Multi-institutional team included Stanford, Harvard, VA Palo Alto, Beth Israel, and others.
- 6Research published in Nature Medicine (February 2025) and Nature Digital Medicine (March 2026).
Why It Matters
These findings highlight the evolving role of AI as a collaborative 'teammate' for clinicians, indicating potential for AI-driven decision support systems in imaging and broader medical workflows. Understanding the optimal human-AI partnership could shape future practice standards and improve patient care.
Source
EurekAlert
Related News
•EurekAlert
AI Transforms Early Detection and Prediction in Kidney Disease
Artificial intelligence is increasingly enabling earlier detection and improved prediction of kidney disease progression by leveraging complex clinical and imaging data.
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.